<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107626">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01968863</url>
  </required_header>
  <id_info>
    <org_study_id>202224</org_study_id>
    <nct_id>NCT01968863</nct_id>
  </id_info>
  <brief_title>Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues</brief_title>
  <official_title>Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Arkansas, Fayetteville</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this exploratory, laboratory study is to evaluate whether
      noninvasive fluorescence microendoscopic imaging of tissue can assist clinicians in
      detecting dysplastic (precancerous) areas during standard surveillance. This is a study
      designed to evaluate the feasibility of using prototype imaging technology to enhance the
      detection of precancerous changes in various tissues. The results of this laboratory study
      will be used to further develop the technology for clinical application.

      The primary aim of this project will be to investigate what digital image analysis criteria
      can be used to best detect dysplasia in various types of resected tissue.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Statistical measurements of the spatial and intensity distributions of pixels within an image</measure>
    <time_frame>Up to 24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>The statistical measurements will be used to correlate each microendoscope image to a histopathology diagnosis.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Known or Suspected Dysplasia or Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with known or suspected dysplasia or cancer scheduled to undergo either
        endoscopic or surgical resection will be approached for participation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females over the age of 18 scheduled for standard of care resection of
             abnormal tissue

        Exclusion Criteria:

          -  Previous chemotherapy or radiation treatment to the tissue to be resected

          -  Inability to provide consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shree Sharma, MD</last_name>
    <phone>501-526-6477</phone>
    <email>sgsharma@uams.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ingrid Johnson</last_name>
    <phone>501-686-8274</phone>
    <email>ibjohnson@uams.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shree Sharma, MD</last_name>
      <phone>501-526-6477</phone>
      <email>sgsharma@uams.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ingrid Johnson</last_name>
      <phone>501-686-8274</phone>
      <email>ibjohnson@uams.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>October 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
